{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:39:43Z","timestamp":1791016783460,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T00:00:00Z","timestamp":1271289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T00:00:00Z","timestamp":1271289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/gt.2010.42","type":"journal-article","created":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T10:30:35Z","timestamp":1271327435000},"page":"913-921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Affinity maturation of an anti-V antigen IgG expressed in situ through adenovirus gene delivery confers enhanced protection against Yersinia pestis challenge"],"prefix":"10.1038","volume":"17","author":[{"given":"T J","family":"Van Blarcom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Sofer-Podesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R G","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,15]]},"reference":[{"key":"BFgt201042_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1128\/IAI.00856-08","volume":"77","author":"C Sofer-Podesta","year":"2009","unstructured":"Sofer-Podesta C, Ang J, Hackett NR, Senina S, Perlin D, Crystal RG et al. Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge. Infect Immun 2009; 77: 1561\u20131568.","journal-title":"Infect Immun"},{"key":"BFgt201042_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","volume":"225","author":"ST Smiley","year":"2008","unstructured":"Smiley ST . Immune defense against pneumonic plague. Immunol Rev 2008; 225: 256\u2013271.","journal-title":"Immunol Rev"},{"key":"BFgt201042_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1196\/annals.1374.041","volume":"1078","author":"P Brouqui","year":"2006","unstructured":"Brouqui P, Raoult D . Arthropod-borne diseases in homeless. Ann N Y Acad Sci 2006; 1078: 223\u2013235.","journal-title":"Ann N Y Acad Sci"},{"key":"BFgt201042_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.micinf.2005.06.006","volume":"8","author":"D Zhou","year":"2006","unstructured":"Zhou D, Han Y, Yang R . Molecular and physiological insights into plague transmission, virulence and etiology. Microbes Infect 2006; 8: 273\u2013284.","journal-title":"Microbes Infect"},{"key":"BFgt201042_CR5","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1128\/IAI.74.5.3068-3070.2006","volume":"74","author":"J Hill","year":"2006","unstructured":"Hill J, Eyles JE, Elvin SJ, Healey GD, Lukaszewski RA, Titball RW et al. Administration of antibody to the lung protects mice against pneumonic plague. Infect Immun 2006; 74: 3068\u20133070.","journal-title":"Infect Immun"},{"key":"BFgt201042_CR6","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1128\/IAI.71.4.2234-2238.2003","volume":"71","author":"J Hill","year":"2003","unstructured":"Hill J, Copse C, Leary S, Stagg AJ, Williamson ED, Titball RW et al. Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis. Infect Immun 2003; 71: 2234\u20132238.","journal-title":"Infect Immun"},{"key":"BFgt201042_CR7","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/iai.65.11.4476-4482.1997","volume":"65","author":"J Hill","year":"1997","unstructured":"Hill J, Leary SE, Griffin KF, Williamson ED, Titball RW . Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun 1997; 65: 4476\u20134482.","journal-title":"Infect Immun"},{"key":"BFgt201042_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nbt0602-597","volume":"20","author":"JA Maynard","year":"2002","unstructured":"Maynard JA, Maassen CB, Leppla SH, Brasky K, Patterson JL, Iverson BL et al. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat Biotechnol 2002; 20: 597\u2013601.","journal-title":"Nat Biotechnol"},{"key":"BFgt201042_CR9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jmb.2007.02.024","volume":"368","author":"H Wu","year":"2007","unstructured":"Wu H, Pfarr DS, Johnson S, Brewah YA, Woods RM, Patel NK et al. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J Mol Biol 2007; 368: 652\u2013665.","journal-title":"J Mol Biol"},{"issue":"Suppl 8","key":"BFgt201042_CR10","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1002\/mds.20023","volume":"19","author":"JD Marks","year":"2004","unstructured":"Marks JD . Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization. Mov Disord 2004; 19 (Suppl 8): S101\u2013S108.","journal-title":"Mov Disord"},{"key":"BFgt201042_CR11","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1073\/pnas.91.9.3809","volume":"91","author":"CF Barbas 3rd","year":"1994","unstructured":"Barbas 3rd CF, Hu D, Dunlop N, Sawyer L, Cababa D, Hendry RM et al. In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proc Natl Acad Sci USA 1994; 91: 3809\u20133813.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201042_CR12","doi-asserted-by":"publisher","first-page":"8362","DOI":"10.1128\/IAI.73.12.8362-8368.2005","volume":"73","author":"R Mabry","year":"2005","unstructured":"Mabry R, Rani M, Geiger R, Hubbard GB, Carrion Jr R, Brasky K et al. Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region. Infect Immun 2005; 73: 8362\u20138368.","journal-title":"Infect Immun"},{"key":"BFgt201042_CR13","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1111\/j.1742-4658.2005.04687.x","volume":"272","author":"L Ria\u00f1o-Umbarila","year":"2005","unstructured":"Ria\u00f1o-Umbarila L, Ju\u00e1rez-Gonz\u00e1lez VR, Olamendi-Portugal T, Ort\u00edz-Le\u00f3n M, Possani LD, Becerril B et al. A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom. FEBS J 2005; 272: 2591\u20132601.","journal-title":"FEBS J"},{"key":"BFgt201042_CR14","doi-asserted-by":"publisher","first-page":"8466","DOI":"10.1073\/pnas.0503543102","volume":"102","author":"A Rajpal","year":"2005","unstructured":"Rajpal A, Beyaz N, Haber L, Cappuccilli G, Yee H, Bhatt RR et al. A general method for greatly improving the affinity of antibodies by using combinatorial libraries. Proc Natl Acad Sci USA 2005; 102: 8466\u20138471.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201042_CR15","doi-asserted-by":"publisher","first-page":"9193","DOI":"10.1073\/pnas.0400187101","volume":"101","author":"BR Harvey","year":"2004","unstructured":"Harvey BR, Georgiou G, Hayhurst A, Jeong KJ, Iverson BL, Rogers GK et al. Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries. Proc Natl Acad Sci USA 2004; 101: 9193\u20139198.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201042_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0022-1759(03)00100-5","volume":"276","author":"A Hayhurst","year":"2003","unstructured":"Hayhurst A, Happe S, Mabry R, Koch Z, Iverson BL, Georgiou G et al. Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis. J Immunol Methods 2003; 276: 185\u2013196.","journal-title":"J Immunol Methods"},{"key":"BFgt201042_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/prep.1999.1164","volume":"18","author":"A Hayhurst","year":"2000","unstructured":"Hayhurst A . Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain. Protein Expr Purif 2000; 18: 1\u201310.","journal-title":"Protein Expr Purif"},{"key":"BFgt201042_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y","volume":"25","author":"AC Martin","year":"1996","unstructured":"Martin AC . Accessing the Kabat antibody sequence database by computer. Proteins 1996; 25: 130\u2013133.","journal-title":"Proteins"},{"key":"BFgt201042_CR19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1073\/pnas.92.5.1254","volume":"92","author":"J Foote","year":"1995","unstructured":"Foote J, Eisen HN . Kinetic and affinity limits on antibodies produced during immune responses. Proc Natl Acad Sci USA 1995; 92: 1254\u20131256.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201042_CR20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1128\/IAI.73.2.795-802.2005","volume":"73","author":"N Mohamed","year":"2005","unstructured":"Mohamed N, Clagett M, Li J, Jones S, Pincus S, D'Alia G et al. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge. Infect Immun 2005; 73: 795\u2013802.","journal-title":"Infect Immun"},{"key":"BFgt201042_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nbt1087","volume":"23","author":"J Fang","year":"2005","unstructured":"Fang J, Qian JJ, Yi S, Harding TC, Tu GH, VanRoey M et al. Stable antibody expression at therapeutic levels using the 2A peptide. Nat Biotechnol 2005; 23: 584\u2013590.","journal-title":"Nat Biotechnol"},{"key":"BFgt201042_CR22","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1158\/1078-0432.CCR-06-0746","volume":"12","author":"M Jiang","year":"2006","unstructured":"Jiang M, Shi W, Zhang Q, Wang X, Guo M, Cui Z et al. Gene therapy using adenovirus-mediated full-length anti-HER-2 antibody for HER-2 overexpression cancers. Clin Cancer Res 2006; 12: 6179\u20136185.","journal-title":"Clin Cancer Res"},{"key":"BFgt201042_CR23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/sj.cgt.7700376","volume":"8","author":"S BenAmmar-Ceccoli","year":"2001","unstructured":"BenAmmar-Ceccoli S, Humblot S, Crouzier R, Acres B, Kieny MP, Herlyn D et al. Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth. Cancer Gene Ther 2001; 8: 815\u2013826.","journal-title":"Cancer Gene Ther"},{"key":"BFgt201042_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.addr.2006.03.011","volume":"58","author":"AL Daugherty","year":"2006","unstructured":"Daugherty AL, Mrsny RJ . Formulation and delivery issues for monoclonal antibody therapeutics. Adv Drug Deliv Rev 2006; 58: 686\u2013706.","journal-title":"Adv Drug Deliv Rev"},{"key":"BFgt201042_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/07853890802698842","volume":"41","author":"H Samaranayake","year":"2009","unstructured":"Samaranayake H, Wirth T, Schenkwein D, R\u00e4ty JK, Yl\u00e4-Herttuala S . Challenges in monoclonal antibody-based therapies. Ann Med 2009; 41: 322\u2013331.","journal-title":"Ann Med"},{"key":"BFgt201042_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1634\/theoncologist.2008-0012","volume":"13","author":"CH Chung","year":"2008","unstructured":"Chung CH . Managing premedications and the risk for reactions to infusional monoclonal antibody therapy. Oncologist 2008; 13: 725\u2013732.","journal-title":"Oncologist"},{"key":"BFgt201042_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/0091270005283282","volume":"46","author":"A Joshi","year":"2006","unstructured":"Joshi A, Bauer R, Kuebler P, White M, Leddy C, Compton P et al. An overview of the pharmacokinetics and pharmacodynamics of efalizumab: a monoclonal antibody approved for use in psoriasis. J Clin Pharmacol 2006; 46: 10\u201320.","journal-title":"J Clin Pharmacol"},{"key":"BFgt201042_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/hum.2005.16.157","volume":"16","author":"JL Boyer","year":"2005","unstructured":"Boyer JL, Kobinger G, Wilson JM, Crystal RG . Adenovirus-based genetic vaccines for biodefense. Hum Gene Ther 2005; 16: 157\u2013168.","journal-title":"Hum Gene Ther"},{"key":"BFgt201042_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.mt.6300344","volume":"16","author":"BP De","year":"2008","unstructured":"De BP, Hackett NR, Crystal RG, Boyer JL . Rapid\/sustained anti-anthrax passive immunity mediated by co-administration of Ad\/AAV. Mol Ther 2008; 16: 203\u2013209.","journal-title":"Mol Ther"},{"key":"BFgt201042_CR30","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1128\/IAI.73.10.6885-6891.2005","volume":"73","author":"M Hashimoto","year":"2005","unstructured":"Hashimoto M, Boyer JL, Hackett NR, Wilson JM, Crystal RG . Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity. Infect Immun 2005; 73: 6885\u20136891.","journal-title":"Infect Immun"},{"key":"BFgt201042_CR31","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1073\/pnas.0508123103","volume":"103","author":"GA Lazar","year":"2006","unstructured":"Lazar GA, Dang W, Karki S, Vafa O, Peng JS, Hyun L et al. Engineered antibody Fc variants with enhanced effector function. Proc Natl Acad Sci USA 2006; 103: 4005\u20134010.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201042_CR32","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1086\/507644","volume":"194","author":"MJ Chiuchiolo","year":"2006","unstructured":"Chiuchiolo MJ, Boyer JL, Krause A, Senina S, Hackett NR, Crystal RG et al. Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen. J Infect Dis 2006; 194: 1249\u20131257.","journal-title":"J Infect Dis"},{"key":"BFgt201042_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/89281","volume":"19","author":"G Chen","year":"2001","unstructured":"Chen G, Hayhurst A, Thomas JG, Harvey BR, Iverson BL, Georgiou G et al. Isolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS). Nat Biotechnol 2001; 19: 537\u2013542.","journal-title":"Nat Biotechnol"},{"key":"BFgt201042_CR34","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/nprot.2008.176","volume":"3","author":"Y Mazor","year":"2008","unstructured":"Mazor Y, Van Blarcom T, Iverson BL, Georgiou G . E-clonal antibodies: selection of full-length IgG antibodies using bacterial periplasmic display. Nat Protoc 2008; 3: 1766\u20131777.","journal-title":"Nat Protoc"},{"key":"BFgt201042_CR35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jmb.2007.03.068","volume":"369","author":"B Ribnicky","year":"2007","unstructured":"Ribnicky B, Van Blarcom T, Georgiou G . A scFv antibody mutant isolated in a genetic screen for improved export via the twin arginine transporter pathway exhibits faster folding. J Mol Biol 2007; 369: 631\u2013639.","journal-title":"J Mol Biol"},{"key":"BFgt201042_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/abio.1995.1050","volume":"224","author":"M Fromant","year":"1995","unstructured":"Fromant M, Blanquet S, Plateau P . Direct random mutagenesis of gene-sized DNA fragments using polymerase chain reaction. Anal Biochem 1995; 224: 347\u2013353.","journal-title":"Anal Biochem"},{"key":"BFgt201042_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/(SICI)1099-1352(199909\/10)12:5<279::AID-JMR473>3.0.CO;2-3","volume":"12","author":"DG Myszka","year":"1999","unstructured":"Myszka DG . Improving biosensor analysis. J Mol Recognit 1999; 12: 279\u2013284.","journal-title":"J Mol Recognit"},{"key":"BFgt201042_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0092-8674(92)90213-V","volume":"68","author":"MA Rosenfeld","year":"1992","unstructured":"Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143\u2013155.","journal-title":"Cell"},{"key":"BFgt201042_CR39","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/jvi.70.11.7498-7509.1996","volume":"70","author":"N Mittereder","year":"1996","unstructured":"Mittereder N, March KL, Trapnell BC . Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 1996; 70: 7498\u20137509.","journal-title":"J Virol"},{"key":"BFgt201042_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jmb.2005.04.049","volume":"350","author":"H Wu","year":"2005","unstructured":"Wu H, Pfarr DS, Tang Y, An LL, Patel NK, Watkins JD et al. Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization. J Mol Biol 2005; 350: 126\u2013144.","journal-title":"J Mol Biol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201042","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T09:25:22Z","timestamp":1661246722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,15]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["BFgt201042"],"URL":"https:\/\/doi.org\/10.1038\/gt.2010.42","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,15]]},"assertion":[{"value":"9 November 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}